Chinese institutes publish complete Nipponbare rice reference genome
Time:2024-04-30 02:03:13 Source:sportViews(143)
BEIJING, Aug. 27 (Xinhua) -- Chinese institutes have released a complete assembly of the reference genome of Nipponbare rice, according to the Agricultural Genomics Institute at Shenzhen (AGIS).
In 2005, the reference genome of the current commonly used Nipponbare rice was initially released, confirming that this rice research had entered the era of genomics.
However, there was a long-standing barrier that had hidden three percent of the genome from sequence-based analysis due to the limitations of sequencing and assembly technology at the time.
The AGIS cooperated with the China National Rice Research Institute, the Institute of Crop Science of Chinese Academy of Agricultural Sciences and Yangzhou University to produce a complete assembly of the rice reference genome T2T-NIP and achieve a complete sequence of this important rice reference genome with 385.7 million base pairs.
T2T-NIP contains 12.5 million base pairs of newly identified sequence, according to the research article recently published in the journal Molecular Plant.
The achievement unlocked complex regions of the genome for rice variational and functional studies, said the article.
Previous:Chinese premier says China's market is always open to foreign businesses
Next:C.J. Sansom, bestselling British author of Tudor crime thriller series, dies at 71
You may also like
- Joe Biden wins Democratic primary in Puerto Rico
- Orioles homer 3 more times in an 11
- Pirates 3B Ke'Bryan Hayes scratched with lower back tightness. Grandal starts rehab assignment
- Yuli Gurriel finalizes minor league deal with Braves, assigned to Triple
- China's travel boom buoys global expectations
- How major US stock indexes fared Tuesday, 4/16/2024
- The Dallas Stars can still score. They are now deeper and more balanced going into the NHL playoffs
- People are calling $700 AI gadget the worst piece of tech they've ever used
- Experts caution against underestimating 'indolent tumors'